Published in Nucleic Acids Res on August 19, 2004
Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci (2006) 2.56
Replication and assembly of human papillomaviruses. J Dent Res (2009) 1.20
Synonymous codon usage influences the local protein structure observed. Nucleic Acids Res (2010) 1.18
Regulation of human papillomavirus gene expression by splicing and polyadenylation. Nat Rev Microbiol (2013) 1.04
Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo. Mol Cell Biol (2005) 1.03
Productive Lifecycle of Human Papillomaviruses that Depends Upon Squamous Epithelial Differentiation. Front Microbiol (2012) 0.98
CRPV genomes with synonymous codon optimizations in the CRPV E7 gene show phenotypic differences in growth and altered immunity upon E7 vaccination. PLoS One (2008) 0.88
Generalized substitution of isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiation. Nucleic Acids Res (2007) 0.88
Synonymous codon changes in the oncogenes of the cottontail rabbit papillomavirus lead to increased oncogenicity and immunogenicity of the virus. Virology (2013) 0.80
Human alpha and beta papillomaviruses use different synonymous codon profiles. Virus Genes (2010) 0.79
Cancer, Warts, or Asymptomatic Infections: Clinical Presentation Matches Codon Usage Preferences in Human Papillomaviruses. Genome Biol Evol (2015) 0.77
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A (1993) 22.33
Translational control in mammalian cells. Annu Rev Biochem (1991) 8.36
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol (1987) 6.65
Central dogma of molecular biology. Nature (1970) 5.89
Translation is a non-uniform process. Effect of tRNA availability on the rate of elongation of nascent polypeptide chains. J Mol Biol (1984) 5.34
Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol (1996) 4.52
Involvement of reverse transcription in the replication of cauliflower mosaic virus: a detailed model and test of some aspects. Cell (1983) 4.37
Codon-anticodon assignment and detection of codon usage trends in seven microbial genomes. Microb Comp Genomics (1997) 4.23
Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J (1987) 3.77
Suppression of the negative effect of minor arginine codons on gene expression; preferential usage of minor codons within the first 25 codons of the Escherichia coli genes. Nucleic Acids Res (1990) 2.38
Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J Virol (1999) 2.35
Effects of a minor isoleucyl tRNA on heterologous protein translation in Escherichia coli. J Bacteriol (1995) 2.14
A channeled tRNA cycle during mammalian protein synthesis. Proc Natl Acad Sci U S A (1995) 2.13
Codon replacement in the PGK1 gene of Saccharomyces cerevisiae: experimental approach to study the role of biased codon usage in gene expression. Mol Cell Biol (1987) 2.06
Dietary selenium affects methylation of the wobble nucleoside in the anticodon of selenocysteine tRNA([Ser]Sec). J Biol Chem (1993) 2.05
Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol (2001) 2.02
Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc Natl Acad Sci U S A (1999) 2.00
Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev (2004) 1.96
A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J Virol (1991) 1.95
Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J Biol Chem (1998) 1.88
Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene. J Virol (2000) 1.69
Amber, ochre and opal suppressor tRNA genes derived from a human serine tRNA gene. EMBO J (1985) 1.68
The deafness-associated mitochondrial DNA mutation at position 7445, which affects tRNASer(UCN) precursor processing, has long-range effects on NADH dehydrogenase subunit ND6 gene expression. Mol Cell Biol (1998) 1.67
Selenium induces changes in the selenocysteine tRNA[Ser]Sec population in mammalian cells. Nucleic Acids Res (1991) 1.65
Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo. J Virol (1990) 1.62
tRNA-like structures of plant viral RNAs: conformational requirements for adenylation and aminoacylation. EMBO J (1983) 1.59
Supramolecular organization of the mammalian translation system. Proc Natl Acad Sci U S A (1994) 1.54
mRNA instability elements in the human papillomavirus type 16 L2 coding region. J Virol (1998) 1.39
DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1. Virology (1998) 1.33
A sequestered pool of aminoacyl-tRNA in mammalian cells. Proc Natl Acad Sci U S A (1992) 1.29
A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol (2003) 1.28
Effect of variation of charged and uncharged tRNA(Trp) levels on ppGpp synthesis in Escherichia coli. J Bacteriol (1989) 1.27
The tRNA-like structure of Turnip yellow mosaic virus RNA is a 3'-translational enhancer. Virology (2004) 1.24
Analysis of the regions coding for transfer RNAs in Kluyveromyces lactis mitochondrial DNA. Nucleic Acids Res (1989) 1.15
Codon usage bias and A+T content variation in human papillomavirus genomes. Virus Res (2003) 1.07
Relationship between protein synthesis and concentrations of charged and uncharged tRNATrp in Escherichia coli. Proc Natl Acad Sci U S A (1990) 1.07
Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology (2002) 1.06
Reticulocyte transfer RNA and hemoglobin synthesis. Science (1975) 1.04
The human papillomavirus type 31 late 3' untranslated region contains a complex bipartite negative regulatory element. J Virol (2002) 1.01
Selenocysteyl-tRNAs recognize UGA in Beta vulgaris, a higher plant, and in Gliocladium virens, a filamentous fungus. Biochem Biophys Res Commun (1992) 0.99
In vivo overexpression and purification of Escherichia coli tRNA(ser). FEBS Lett (1993) 0.98
Changes of tRNA population during compensatory cell proliferation: differential expression of methionine-tRNA species. Arch Biochem Biophys (1997) 0.98
Problems of translating heterologous genes in expression systems: the role of tRNA. Biotechnol Prog (1997) 0.97
Replication of bovine papillomavirus type 1 (BPV-1) DNA in Saccharomyces cerevisiae following infection with BPV-1 virions. J Virol (2002) 0.97
Codon usage-mediated inhibition of HIV-1 gag expression in mammalian cells occurs independently of translation. Tsitologiia (2003) 0.94
In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Cancer Res (1995) 0.92
Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1. J Virol (2002) 0.91
Relationships between transcriptional and translational control of gene expression in Saccharomyces cerevisiae: a multiple regression analysis. J Mol Evol (1999) 0.90
Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine (2001) 0.89
Translation in vitro of codon UGA as tryptophan in Mycoplasma capricolum. Biochimie (1992) 0.88
High level expression of Thermococcus litoralis 4-alpha-glucanotransferase in a soluble form in Escherichia coli with a novel expression system involving minor arginine tRNAs and GroELS. FEBS Lett (1999) 0.87
Modulation of HPV16 E7 translation by tRNAs in eukaryotic cell-free translation systems. Biochem Mol Biol Int (1998) 0.87
Effects of additional sequences directly downstream from the AUG on the expression of GFP gene. Biochim Biophys Acta (2003) 0.86
tRNA1Ser(G34) with the anticodon GGA can recognize not only UCC and UCU codons but also UCA and UCG codons. Biochim Biophys Acta (2003) 0.84
Analysis of acceptor stem base pairing on tRNA(Trp) aminoacylation and function in vivo. J Biol Chem (1994) 0.83
Global protein synthesis shutdown in Autographa californica nucleopolyhedrovirus-infected Ld652Y cells is rescued by tRNA from uninfected cells. Virology (1999) 0.82
Translational nonsense codon suppression as indicator for functional pre-tRNA splicing in transformed Arabidopsis hypocotyl-derived calli. Nucleic Acids Res (2003) 0.82
A mechanism of estrogen action on gene expression at the level of translation. Cancer Res (1976) 0.80
Selenium influences the turnover of selenocysteine tRNA([Ser]Sec) in Chinese hamster ovary cells. J Nutr (2002) 0.79
Improvement of human interferon HUIFNalpha2 and HCV core protein expression levels in Escherichia coli but not of HUIFNalpha8 by using the tRNA(AGA/AGG). Biochem Biophys Res Commun (2002) 0.78
Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication. Nucleic Acids Res (2000) 0.78
Enhanced expression of initiator TRNA(Met) in human gastric and colorectal carcinoma. Biochem Mol Biol Int (1997) 0.78
tRNA-assisted overproduction of eukaryotic ribosomal proteins. Protein Expr Purif (2000) 0.78
Infidelity of translation of encephalomyocarditis viral RNA with tRNA from human malignant trophoblastic cells. Biochem Biophys Res Commun (1977) 0.77
Identification of a novel human tRNA(Ser(CGA)) functional in murine leukemia virus replication. Biochim Biophys Acta (2000) 0.77
Functional characterization of naturally occurring mutants of human papillomavirus type 16 with large deletions in the non-coding region. Int J Cancer (1996) 0.76
New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14
Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet (2009) 2.29
Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production. J Immunol (2009) 1.81
Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. J Control Release (2011) 1.77
Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. J Control Release (2009) 1.71
Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. Am J Hum Genet (2009) 1.51
Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell. Cancer Res (2002) 1.30
Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors. J Natl Cancer Inst (2004) 1.28
Sequence variants in three loci influence monocyte counts and erythrocyte volume. Am J Hum Genet (2009) 1.28
Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS One (2010) 1.27
Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. Small (2010) 1.16
HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood. Vaccine (2005) 1.14
Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques. Virology (2002) 1.12
Inhibition of early tumor growth requires J alpha 18-positive (natural killer T) cells. Cancer Res (2003) 1.09
Codon usage bias and A+T content variation in human papillomavirus genomes. Virus Res (2003) 1.07
Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology (2002) 1.06
IL10 and IL12B polymorphisms each influence IL-12p70 secretion by dendritic cells in response to LPS. Immunol Cell Biol (2006) 1.05
Regulation of immune responses to HPV infection and during HPV-directed immunotherapy. Immunol Rev (2011) 1.05
Development of therapeutic HPV vaccines. Lancet Oncol (2009) 1.04
Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo. Mol Cell Biol (2005) 1.03
Chapter 16: Prophylactic human papillomavirus vaccines. J Natl Cancer Inst Monogr (2003) 1.02
Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model. PLoS One (2010) 1.02
Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. Virology (2004) 0.99
Replication of bovine papillomavirus type 1 (BPV-1) DNA in Saccharomyces cerevisiae following infection with BPV-1 virions. J Virol (2002) 0.97
Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen. J Immunol (2010) 0.96
NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins. J Immunol (2011) 0.94
Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-kappaB-mediated signalling, moderated by TGF-beta. Immunol Cell Biol (2005) 0.93
Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16. Immunol Cell Biol (2003) 0.93
Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7. J Invest Dermatol (2013) 0.92
Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu. Cancer Prev Res (Phila) (2012) 0.92
Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. J Control Release (2012) 0.92
Activation of PI3K/Akt/mTOR pathway and dual inhibitors of PI3K and mTOR in endometrial cancer. Curr Med Chem (2014) 0.91
Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1. J Virol (2002) 0.91
Multivariate QTL linkage analysis suggests a QTL for platelet count on chromosome 19q. Eur J Hum Genet (2004) 0.91
IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host. J Immunol (2009) 0.90
Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4+CD25+ T cells. Eur J Immunol (2009) 0.90
Overcoming original antigenic sin to generate new CD8 T cell IFN-gamma responses in an antigen-experienced host. J Immunol (2006) 0.90
Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes. PLoS One (2013) 0.89
Major quantitative trait locus for eosinophil count is located on chromosome 2q. J Allergy Clin Immunol (2004) 0.89
New Approaches to Immunotherapy for HPV Associated Cancers. Cancers (Basel) (2011) 0.89
Generalized substitution of isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiation. Nucleic Acids Res (2007) 0.88
LPAR1 and ITGA4 regulate peripheral blood monocyte counts. Hum Mutat (2011) 0.87
Phosphatidylinositol 3-kinase signaling as a therapeutic target for cervical cancer. Curr Cancer Drug Targets (2013) 0.87
Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes. J Gen Virol (2013) 0.86
Route of administration of chimeric BPV1 VLP determines the character of the induced immune responses. Immunol Cell Biol (2002) 0.86
ISCOMATRIX adjuvant: an adjuvant suitable for use in anticancer vaccines. Vaccine (2004) 0.86
Effects of additional sequences directly downstream from the AUG on the expression of GFP gene. Biochim Biophys Acta (2003) 0.86
A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice. PLoS One (2013) 0.86
A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin. J Immunol (2012) 0.85
Predictive factors for clinical response to allergy immunotherapy in children with asthma and rhinitis. Int Arch Allergy Immunol (2014) 0.85
Prediction of conserved microRNAs from skin and mucosal human papillomaviruses. Arch Virol (2011) 0.84
Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide. Immunol Cell Biol (2002) 0.84
TLR7 stimulation augments T effector-mediated rejection of skin expressing neo-self antigen in keratinocytes. Eur J Immunol (2008) 0.84
The number of long-lasting functional memory CD8+ T cells generated depends on the nature of the initial nonspecific stimulation. Eur J Immunol (2002) 0.83
Changes to peptide structure, not concentration, contribute to expansion of the lowest avidity cytotoxic T lymphocytes. J Leukoc Biol (2004) 0.83
Evaluation of a cervical cancer screening program based on HPV testing and LLETZ excision in a low resource setting. PLoS One (2010) 0.82
Calcium enhances mouse keratinocyte differentiation in vitro to differentially regulate expression of papillomavirus authentic and codon modified L1 genes. Virology (2007) 0.82
IL-10 mediates suppression of the CD8 T cell IFN-gamma response to a novel viral epitope in a primed host. J Immunol (2003) 0.82
Antigen-specific CD4 cells assist CD8 T-effector cells in eliminating keratinocytes. J Invest Dermatol (2010) 0.82
HPV vaccines: the beginning of the end for cervical cancer. Curr Opin Immunol (2007) 0.82
Increasing mechanical stimulus induces migration of Langerhans cells and impairs the immune response to intracutaneously delivered antigen. Exp Dermatol (2011) 0.82
Diamantina Health Partners: integrating leadership in research, research translation, education and clinical care. Med J Aust (2012) 0.81
Mutations in TAP genes are common in cervical carcinomas. Gynecol Oncol (2004) 0.80
Comprehensive analysis of prokaryotic mechanosensation genes: their characteristics in codon usage. DNA Seq (2007) 0.80
Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin. J Control Release (2011) 0.79
The early monocytic response to cytomegalovirus infection is MyD88 dependent but occurs independently of common inflammatory cytokine signals. Eur J Immunol (2013) 0.79
Obesity-associated endometrial and cervical cancers. Front Biosci (Elite Ed) (2013) 0.79
Nuclear RelB+ cells are found in normal lymphoid organs and in peripheral tissue in the context of inflammation, but not under normal resting conditions. Immunol Cell Biol (2002) 0.79
γδ T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen. J Invest Dermatol (2012) 0.79
Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis. Arthritis Res Ther (2007) 0.79
Antigen-specific CD8 T cells can eliminate antigen-bearing keratinocytes with clonogenic potential via an IFN-gamma-dependent mechanism. J Invest Dermatol (2010) 0.79
Finding a vaccine for human papillomavirus. Lancet (2006) 0.78
Impact of sex steroid ablation on viral, tumour and vaccine responses in aged mice. PLoS One (2012) 0.78
Status of asthma control in children and the effect of parents' knowledge, attitude, and practice (KAP) in China: a multicenter study. Ann Allergy Asthma Immunol (2012) 0.78
Expression of papillomavirus L1 proteins regulated by authentic gene codon usage is favoured in G2/M-like cells in differentiating keratinocytes. Virology (2010) 0.78
Keratinocytes efficiently process endogenous antigens for cytotoxic T-cell mediated lysis. Exp Dermatol (2009) 0.78
Constitutive activation of signal transducer and activator of transcription 3 regulates expression of vascular endothelial growth factor in human meningioma differentiation. J Cancer Res Clin Oncol (2010) 0.78
Tumour susceptibility to innate and adaptive immunotherapy changes during tumour maturation. Immunol Cell Biol (2004) 0.78
Human papillomavirus 16 E7 protein inhibits interferon-γ-mediated enhancement of keratinocyte antigen processing and T-cell lysis. FEBS J (2011) 0.77
Differential expression of papillomavirus L1 proteins encoded by authentic and codon modified L1 genes in methylcellulose-treated mouse keratinocytes. Virol J (2007) 0.77
Up-regulated expression of Sp1 protein coincident with a viral protein in human and mouse differentiating keratinocytes may act as a cell differentiation marker. Differentiation (2008) 0.77
Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection. Immunol Cell Biol (2004) 0.77
Recombinant Wnt3a and Wnt5a elicit macrophage cytokine production and tolerization to microbial stimulation via Toll-like receptor 4. Eur J Immunol (2014) 0.76
Interleukin-17A Promotes Arginase-1 Production and 2,4-Dinitrochlorobenzene-Induced Acute Hyperinflammation in Human Papillomavirus E7 Oncoprotein-Expressing Skin. J Innate Immun (2015) 0.76
A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice. Acta Biochim Biophys Sin (Shanghai) (2014) 0.76
A randomized trial of immunotherapy for persistent genital warts. Hum Vaccin Immunother (2012) 0.75
An optimized yeast cell-free system: sufficient for translation of human papillomavirus 58 L1 mRNA and assembly of virus-like particles. J Biosci Bioeng (2008) 0.75
IL-1 signalling determines the fate of skin grafts expressing non-self protein in keratinocytes. Exp Dermatol (2010) 0.75
DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection. J Immunother (2017) 0.75
Expression of HPV 58 long and short L1 capsid proteins in primary mouse keratinocyte cultures. Protein Pept Lett (2009) 0.75
TNF-α promotes IFN-γ-induced CD40 expression and antigen process in Myb-transformed hematological cells. ScientificWorldJournal (2012) 0.75
The properties of CpG islands in the putative promoter regions of human immunoglobulin (Ig) genes. Gene (2005) 0.75
The influence of inhaled corticosteroid discontinuation in children with well-controlled asthma. Medicine (Baltimore) (2017) 0.75
Computational analysis of base composition pattern and promoter elements in the putative promoter regions in relation to expression profiles of 682 human genes on chromosome 22. DNA Seq (2006) 0.75